Skip to main content

When CGM Data Access Breaks Down: Why Transparency Matters More Than Ever

Blog
Date: 12.16.2025

Continuous glucose monitoring (CGM) data has become foundational to many digital health products. From clinical decision support to patient engagement and population health programs, reliable CGM data is no longer optional—it’s mission-critical.

Yet recently, many organizations have encountered unexpected disruptions or limitations in their CGM data access. In many cases, the root cause wasn’t technical. It was a lack of transparency.

The Hidden Risk in CGM Integrations

Not all CGM data integrations are created equal. While some vendors provide access on the surface, underlying agreements with device manufacturers may impose limitations that aren’t always clearly disclosed upfront.

When those limitations surface later—through changes in policy, access restrictions, or revoked connections—the impact can be significant:

  • Product roadmaps are delayed or forced to change

  • End users lose trust when data suddenly disappears

  • Teams are left scrambling to explain disruptions they didn’t anticipate

For organizations building on CGM data, this kind of uncertainty creates long-term risk.

Why Manufacturer Approval Matters

Accessing CGM data isn’t just a technical integration—it’s a regulated, permission-based process that requires formal approval from device manufacturers.

Working outside of that process can introduce fragility into your data strategy. Without clear manufacturer alignment:

  • Access may be limited or revoked without notice

  • Compliance expectations may be unclear

  • Long-term scalability becomes uncertain

A sustainable CGM integration depends on transparency, documented approvals, and clearly defined expectations from day one.

A More Reliable Approach to CGM Data Access

Validic takes a different approach.

We maintain established, transparent relationships with leading CGM manufacturers, including Dexcom and Abbott, and support organizations through the formal approval process required to access CGM data.

This ensures:

  • Compliance with manufacturer requirements

  • Clear understanding of data access and use boundaries

  • Reliable, long-term data availability

By prioritizing transparency and alignment, teams can build with confidence—without fear of sudden disruption.

Stability Comes From Experience

With more than 10 years of experience supporting digital health organizations, Validic has built its platform around reliability and trust.

Our clients rely on us not just to connect data, but to deliver it consistently—at scale, and over time. That experience becomes especially critical as data ecosystems grow more complex and regulatory scrutiny increases.

Beyond CGM: Simplifying the Health Data Stack

While CGM data is often the starting point, many organizations quickly discover the operational burden of managing multiple device integrations and vendors.

Validic supports personal health data from 700+ consumer wearables and clinical devices through a single, scalable platform—helping teams:

  • Consolidate vendors

  • Reduce integration and maintenance overhead

  • Simplify their data infrastructure as they grow

Building for the Long Term

In a data-driven healthcare environment, reliability isn’t a nice-to-have—it’s a requirement.

As organizations evaluate their CGM and health data strategies, transparency, manufacturer alignment, and proven experience should be core criteria—not afterthoughts.

If your team is navigating CGM data challenges or re-evaluating how you access and manage device data, now is the time to ensure your foundation is built to last.


Get started today.